This company seems to have been delisted
Reason: Merged with Trawsfynydd Therapeutics to form Traws Pharma
Last recorded trade on: June 5, 2024
Source: https://investor.onconova.com/news-releases/news-release-details/onconova-therapeutics-inc-and-trawsfynydd-therapeutics-inc
Reason: Merged with Trawsfynydd Therapeutics to form Traws Pharma
Last recorded trade on: June 5, 2024
Source: https://investor.onconova.com/news-releases/news-release-details/onconova-therapeutics-inc-and-trawsfynydd-therapeutics-inc
Onconova Therapeutics
ONTX
HK$7.74
Share price
-0.47%
Change (1 day)
-10.88%
Change (1 year)
Categories
Onconova Therapeutics (ONTX) - P/B ratio
P/B ratio as of March 2025 : 3.48
According to Onconova Therapeutics's latest financial reports the company has a price-to-book ratio of 92.4986.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Onconova Therapeutics - P/B ratio (from 2013 to 2024)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2024-12-31 | N/A | -100% |
| 2023-12-31 | 1.47 | 207.44% |
| 2022-12-31 | 0.4773 | -58.68% |
| 2021-12-31 | 1.16 | -91.72% |
| 2020-12-31 | 14.0 | 279.25% |
| 2019-12-31 | 3.68 | 65.52% |
| 2018-12-31 | 2.22 | -249.4% |
| 2017-12-31 | -1.49 | -149.7% |
| 2016-12-31 | 2.99 | 33.16% |
| 2015-12-31 | 2.25 | -25.64% |
| 2014-12-31 | 3.02 | -0.77% |
| 2013-12-31 | 3.05 | |
| 2012-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | P/B ratio differencediff. | Country |
|---|---|---|---|
 | 7.89 | 126.93% | 🇺🇸 USA |
 | 3.03 | -12.85% | 🇺🇸 USA |
 | 2.41 | -30.58% | 🇺🇸 USA |
 | -47.3 | -1,460.84% | 🇺🇸 USA |